Stay updated on Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The NIH terminology-transition announcement banner was removed from the page. The underlying study page still displays a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-11-10T15:54:48.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the study page remains unavailable with a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-11-03T16:38:31.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    A sitewide notice about NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” appears above the page, and the footer revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T18:42:11.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The site’s footer revision number changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T19:08:07.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page previously displayed a 403 Forbidden error, and now shows the full study record for the trial, including the overview, design, primary and secondary outcomes, eligibility criteria, and contacts/locations.
    Difference
    100%
    Check dated 2026-09-29T19:25:26.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with a simple error screen and a Home link. Users cannot view the study details or related information on this page.
    Difference
    17%
    Check dated 2026-09-22T22:13:57.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.